Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "TD"

1481 News Found

RedHill secures final $10.5M court judgment for enforcement
Biopharma | November 06, 2025

RedHill secures final $10.5M court judgment for enforcement

RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment


Zydus receives FDA’s tentative approval for Budesonide delayedrelease capsules, 4 mg
Drug Approval | November 05, 2025

Zydus receives FDA’s tentative approval for Budesonide delayedrelease capsules, 4 mg

Budesonide is indicated for mild to moderate active Crohn's disease involving the ileum and/or the ascending colon in adults and children 8 years of age and olde


Effective corrosion management demands a holistic approach: Experts
News | November 04, 2025

Effective corrosion management demands a holistic approach: Experts

From material selection to cooling tower management, every small decision affects long-term equipment reliability


Gland Pharma reports Q2 FY26 PAT higher at Rs. 184 Cr
News | November 04, 2025

Gland Pharma reports Q2 FY26 PAT higher at Rs. 184 Cr

Revenue for the quarter rose 5.8% to Rs. 1,487 crore as compared to Rs. 1,406 crore in the corresponding quarter of the previous fiscal


Alkem Foundation and IIT Bombay collaborate to set up advanced research centre for immuno-therapeutics, regenerative medicines
R&D | November 03, 2025

Alkem Foundation and IIT Bombay collaborate to set up advanced research centre for immuno-therapeutics, regenerative medicines

This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines


Dr Lal Path Labs reports consolidated Q2 FY26 PAT at Rs. 150.6 Cr
News | November 02, 2025

Dr Lal Path Labs reports consolidated Q2 FY26 PAT at Rs. 150.6 Cr

The company has posted net profit of Rs. 283 crore for the 6 months period ended September 30, 2025


Tatva Chintan Pharma Chem reports consolidated Q2 FY26 PAT at Rs. 9.91 Cr
News | November 02, 2025

Tatva Chintan Pharma Chem reports consolidated Q2 FY26 PAT at Rs. 9.91 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 124.52 crore during the period ended September 30, 2025


Zydus Wellness appoints Manish Lal as Head, Global Demand and Supply Organization
People | November 02, 2025

Zydus Wellness appoints Manish Lal as Head, Global Demand and Supply Organization

With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors


Akums breaks ground for its first overseas manufacturing facility in Zambia
News | October 28, 2025

Akums breaks ground for its first overseas manufacturing facility in Zambia

It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products


Zydus receives approval from Health Canada for Mesalamine suppositories
News | October 27, 2025

Zydus receives approval from Health Canada for Mesalamine suppositories

Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis